Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04830202
Title Expanded Access to Telisotuzumab Vedotin
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ISR | DEU | AUS

Facility Status City State Zip Country Details
Sutter Medical Group /ID# 254816 AVAILABLE Sacramento California 95816 United States Details
Oncology & Hematology Specialist /ID# 248083 AVAILABLE Mountain Lakes New Jersey 07046-1743 United States Details
Western Heamatology and Oncology Clinics /ID# 243364 AVAILABLE West Perth Western Australia 6005 Australia Details
University Hospital Cologne /ID# 254773 AVAILABLE Cologne 50937 Germany Details
Asklepios Fachkliniken Muenchen-Gauting /ID# 259196 AVAILABLE Gauting 82131 Germany Details
Hong Kong United Oncology Centre /ID# 241857 AVAILABLE Yau Ma Tei Hong Kong Details
The Chaim Sheba Medical Center /ID# 256530 AVAILABLE Ramat Gan Tel-Aviv 5265601 Israel Details
Shaare Zedek Medical Center /ID# 252374 AVAILABLE Jerusalem 91031 Israel Details
Rabin Medical Center /ID# 228611 AVAILABLE Petakh Tikva 4941492 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field